IMMUNOTHERAPY CONFERENCE


Immunotherapy Conference is one of the leading research topics in the international research conference domain. Immunotherapy is a conference track under the Healthcare Conference which aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Healthcare.

internationalconference.net provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of (Healthcare).

Immunotherapy is not just a call for academic papers on the topic; it can also include a conference, event, symposium, scientific meeting, academic, or workshop.

You are welcome to SUBMIT your research paper or manuscript to Immunotherapy Conference Track will be held at “Healthcare Conference in Barcelona, Spain in April 2020” - “Healthcare Conference in Istanbul, Turkey in May 2020” - “Healthcare Conference in San Francisco, United States in June 2020” - “Healthcare Conference in Paris, France in July 2020” - “Healthcare Conference in New York, United States in August 2020” - “Healthcare Conference in Tokyo, Japan in September 2020” - “Healthcare Conference in Zürich, Switzerland in September 2020” - “Healthcare Conference in Barcelona, Spain in October 2020” - “Healthcare Conference in San Francisco, United States in November 2020” - “Healthcare Conference in Istanbul, Turkey in November 2020” - “Healthcare Conference in Singapore, Singapore in November 2020” - “Healthcare Conference in Bangkok, Thailand in December 2020” - “Healthcare Conference in Paris, France in December 2020” .

Immunotherapy is also a leading research topic on Google Scholar, Semantic Scholar, Zenedo, OpenAIRE, BASE, WorldCAT, Sherpa/RoMEO, Elsevier, Scopus, Web of Science.

VII. INTERNATIONAL HEALTHCARE CONFERENCE

APRIL 15 - 16, 2020
BARCELONA, SPAIN

VIII. INTERNATIONAL HEALTHCARE CONFERENCE

MAY 11 - 12, 2020
ISTANBUL, TURKEY

  • Abstracts/Full-Text Paper Submission Deadline February 27, 2020
  • Notification of Acceptance/Rejection Deadline March 12, 2020
  • Final Paper and Early Bird Registration Deadline April 01, 2020
  • CONFERENCE CODE: 20HC05TR
  • One Time Submission Deadline Reminder

IX. INTERNATIONAL HEALTHCARE CONFERENCE

JUNE 05 - 06, 2020
SAN FRANCISCO, UNITED STATES

  • Abstracts/Full-Text Paper Submission Deadline February 27, 2020
  • Notification of Acceptance/Rejection Deadline March 12, 2020
  • Final Paper and Early Bird Registration Deadline May 06, 2020
  • CONFERENCE CODE: 20HC06US
  • One Time Submission Deadline Reminder

X. INTERNATIONAL HEALTHCARE CONFERENCE

JULY 20 - 21, 2020
PARIS, FRANCE

XI. INTERNATIONAL HEALTHCARE CONFERENCE

AUGUST 10 - 11, 2020
NEW YORK, UNITED STATES

  • Abstracts/Full-Text Paper Submission Deadline February 27, 2020
  • Notification of Acceptance/Rejection Deadline March 12, 2020
  • Final Paper and Early Bird Registration Deadline July 10, 2020
  • CONFERENCE CODE: 20HC08US
  • One Time Submission Deadline Reminder

XII. INTERNATIONAL HEALTHCARE CONFERENCE

SEPTEMBER 10 - 11, 2020
TOKYO, JAPAN

  • Abstracts/Full-Text Paper Submission Deadline February 27, 2020
  • Notification of Acceptance/Rejection Deadline March 12, 2020
  • Final Paper and Early Bird Registration Deadline August 10, 2020
  • CONFERENCE CODE: 20HC09JP
  • One Time Submission Deadline Reminder

XIII. INTERNATIONAL HEALTHCARE CONFERENCE

SEPTEMBER 16 - 17, 2020
ZÜRICH, SWITZERLAND

  • Abstracts/Full-Text Paper Submission Deadline February 27, 2020
  • Notification of Acceptance/Rejection Deadline March 12, 2020
  • Final Paper and Early Bird Registration Deadline August 17, 2020
  • CONFERENCE CODE: 20HC09CH
  • One Time Submission Deadline Reminder

XIV. INTERNATIONAL HEALTHCARE CONFERENCE

OCTOBER 21 - 22, 2020
BARCELONA, SPAIN

  • Abstracts/Full-Text Paper Submission Deadline February 27, 2020
  • Notification of Acceptance/Rejection Deadline March 12, 2020
  • Final Paper and Early Bird Registration Deadline September 22, 2020
  • CONFERENCE CODE: 20HC10ES
  • One Time Submission Deadline Reminder

XV. INTERNATIONAL HEALTHCARE CONFERENCE

NOVEMBER 02 - 03, 2020
SAN FRANCISCO, UNITED STATES

  • Abstracts/Full-Text Paper Submission Deadline February 27, 2020
  • Notification of Acceptance/Rejection Deadline March 12, 2020
  • Final Paper and Early Bird Registration Deadline October 05, 2020
  • CONFERENCE CODE: 20HC11US
  • One Time Submission Deadline Reminder

XVI. INTERNATIONAL HEALTHCARE CONFERENCE

NOVEMBER 12 - 13, 2020
ISTANBUL, TURKEY

  • Abstracts/Full-Text Paper Submission Deadline February 27, 2020
  • Notification of Acceptance/Rejection Deadline March 12, 2020
  • Final Paper and Early Bird Registration Deadline October 05, 2020
  • CONFERENCE CODE: 20HC11TR
  • One Time Submission Deadline Reminder

XVII. INTERNATIONAL HEALTHCARE CONFERENCE

NOVEMBER 19 - 20, 2020
SINGAPORE, SINGAPORE

  • Abstracts/Full-Text Paper Submission Deadline February 27, 2020
  • Notification of Acceptance/Rejection Deadline March 12, 2020
  • Final Paper and Early Bird Registration Deadline October 19, 2020
  • CONFERENCE CODE: 20HC11SG
  • One Time Submission Deadline Reminder

XVIII. INTERNATIONAL HEALTHCARE CONFERENCE

DECEMBER 15 - 16, 2020
BANGKOK, THAILAND

  • Abstracts/Full-Text Paper Submission Deadline February 27, 2020
  • Notification of Acceptance/Rejection Deadline March 12, 2020
  • Final Paper and Early Bird Registration Deadline November 17, 2020
  • CONFERENCE CODE: 20HC12TH
  • One Time Submission Deadline Reminder

XIX. INTERNATIONAL HEALTHCARE CONFERENCE

DECEMBER 28 - 29, 2020
PARIS, FRANCE

  • Abstracts/Full-Text Paper Submission Deadline February 27, 2020
  • Notification of Acceptance/Rejection Deadline March 12, 2020
  • Final Paper and Early Bird Registration Deadline November 26, 2020
  • CONFERENCE CODE: 20HC12FR
  • One Time Submission Deadline Reminder
FINISHED

I. INTERNATIONAL HEALTHCARE CONFERENCE

MARCH 19 - 20, 2019
ISTANBUL, TURKEY

FINISHED

II. INTERNATIONAL HEALTHCARE CONFERENCE

JUNE 26 - 27, 2019
PARIS, FRANCE

FINISHED

III. INTERNATIONAL HEALTHCARE CONFERENCE

AUGUST 21 - 22, 2019
LONDON, UNITED KINGDOM

FINISHED

IV. INTERNATIONAL HEALTHCARE CONFERENCE

OCTOBER 08 - 09, 2019
NEW YORK, UNITED STATES

FINISHED

V. INTERNATIONAL HEALTHCARE CONFERENCE

DECEMBER 12 - 13, 2019
ROME, ITALY

FINISHED

VI. INTERNATIONAL HEALTHCARE CONFERENCE

FEBRUARY 13 - 14, 2020
LONDON, UNITED KINGDOM

Healthcare Conference Call For Papers are listed below:

Previously Published Papers on "Immunotherapy Conference"

  • A Recommendation to Oncologists for Cancer Treatment by Immunotherapy: Quantitative and Qualitative Analysis
    Authors: Mandana Kariminejad, Ali Ghaffari, Keywords: Tumor, immunotherapy, fuzzy controller, Genetic algorithm, mathematical model. DOI:10.5281/zenodo.2571682 Abstract: Today, the treatment of cancer, in a relatively short period, with minimum adverse effects is a great concern for oncologists. In this paper, based on a recently used mathematical model for cancer, a guideline has been proposed for the amount and duration of drug doses for cancer treatment by immunotherapy. Dynamically speaking, the mathematical ordinary differential equation (ODE) model of cancer has different equilibrium points; one of them is unstable, which is called the no tumor equilibrium point. In this paper, based on the number of tumor cells an intelligent soft computing controller (a combination of fuzzy logic controller and genetic algorithm), decides regarding the amount and duration of drug doses, to eliminate the tumor cells and stabilize the unstable point in a relatively short time. Two different immunotherapy approaches; active and adoptive, have been studied and presented. It is shown that the rate of decay of tumor cells is faster and the doses of drug are lower in comparison with the result of some other literatures. It is also shown that the period of treatment and the doses of drug in adoptive immunotherapy are significantly less than the active method. A recommendation to oncologists has also been presented.